PBM Execs Stay On Message Amid Growing US Congressional Frustration At Hearing
Executive Summary
The House Oversight Committee held its third hearing on pharmacy benefit manager reforms in 10 months, but could not elicit an admission from executives that they are responsible for increasing drug prices.